WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

2020-August-17	WuXi Biologics Records Excellent Interim Results, Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million, Net Profit Up 62.6% to RMB730.7 Million, Profit Attributable to Owners of the Company Up 63.6% Y-o-Y to RMB736.1 Million, Adjusted Net Profit Up 40.7% Y-o-Y to RMB734.0 Million, Diluted EPS Up 55.9% Y-o-Y to RMB0.53, Adjusted Diluted EPS Up 38.5% Y-o-Y to RMB0.54, Total Backlog Surges to US$9,464.0 Million (in PDF)
2020-March-26	WuXi Biologics Achieved Remarkable Results in 2019 (in PDF)
2022	2022 Press Releases
2021	2021 Press Releases
2019	2019 Press Releases
2018	2018 Press Releases
2017	2017 Press Releases